The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.
When implementing IVDR requirements, it’s important to take a step back and look at the flow of documents.
Pharmaceutical companies have long been subject to the kinds of rigorous electronic reporting standards that will soon affect medical device manufacturers. What can be gleaned from their experiences?
Manufacturers must re-evaluate existing regulatory and compliance strategies to meet the new requirements.